Description
Cinacalcet tablets are a medication used to treat secondary hyperparathyroidism (HPT) in patients with chronic kidney disease and parathyroid carcinoma. Secondary HPT occurs when the parathyroid glands produce too much parathyroid hormone (PTH) due to imbalances in calcium and phosphorus levels caused by kidney dysfunction. Cinacalcet works by binding to calcium-sensing receptors on the parathyroid gland, thereby reducing PTH secretion and helping to regulate calcium levels.
These tablets are typically taken orally and are available in various strengths as prescribed by healthcare professionals. Proper dosage and usage instructions should be followed closely to achieve optimal therapeutic outcomes while minimizing potential side effects. Common side effects may include nausea, vomiting, diarrhea, and headaches. Serious adverse reactions such as hypocalcemia (low calcium levels) or allergic reactions are possible but rare.
It is crucial to inform your healthcare provider about any existing medical conditions, ongoing treatments, or medications you are taking before starting cinacalcet therapy to prevent potential interactions and ensure safe usage. Regular monitoring of calcium and phosphorus levels is often recommended during treatment.
